AI-Enabled Integrated Dementia & Domiciliary Care Intelligence Platform for UK care providers.
CalmPath is a closed-loop clinical system that turns routine dementia care into structured, learning evidence — matching non-pharmacological interventions to each person, correlating outcomes with PRN psychotropic use, and generating CQC-ready proof of person-centred care.
Capital is committed to medication before evidence-based alternatives are ever tried.
Antipsychotic and sedative overuse in dementia is an explicit patient-safety priority for the NHS Long-Term Plan and CQC — not a matter of clinical debate. Care providers currently have no tools to measure whether structured non-pharmacological care is actually reducing medication burden.
Agitation, restlessness or distress emerges — often at predictable times of day.
Frontline carers lack decision support, protocols and confidence in non-pharmacological options.
Antipsychotics or sedatives are administered off-label, at doses or durations not supported by clinical guidance.
1.5–2× stroke risk, 1.5–1.8× mortality risk, falls and sedation — with no data linking care quality to medication use.
Up to 70–80% of these prescriptions are at doses or durations not supported by clinical guidance — meaning 125,000–145,000 people are likely on inappropriate antipsychotic medication today.
Five Integrated Modules — from informal, unmeasured care to a closed-loop clinical intelligence layer.
A 2026 independent novelty search confirmed no existing solution combines the closed-loop personalised intervention engine, the Medication-Outcome Correlation Engine and integrated escalation-and-governance in a single platform.
Dementia Care & Cognitive Core
Personalised protocol library, cognitive stimulation, digital life-story book, emotional wellbeing tracker and reminiscence aids — a Closed-Loop Intervention Engine that learns which non-pharmacological approach works for each person.
Clinical Safety & Early Detection
Structured daily morning check-in, decision support for UTIs, dehydration, delirium and falls, automated SBAR escalation and Constraint-Aware Predictive Risk Flagging — so no sign of deterioration is missed.
Holistic Wellbeing & Companionship
Video and phone companion sessions, a healing and relaxation hub, personalised wellbeing calendar and reminiscence content — accessible, person-centred engagement that combats isolation.
Workforce Enablement
Just-in-time CQC, MCA and safeguarding guidance, carer wellbeing assessment, an AI care assistant for documentation, and a recognition system — reducing burnout and turnover.
Family & Governance Intelligence
Consent-controlled Family Portal, auto-generated CQC Evidence Dashboard and full audit trail — plus the Medication-Outcome Correlation Engine, which holds non-pharmacological outcomes and PRN psychotropic administration in one data model to generate the evidence clinicians need for safer, Clinician-led Medication Review.
Every observation becomes evidence. Every outcome sharpens the next recommendation.
Carer observes and logs a trigger — e.g. agitation at 3 pm.
System matches the trigger against the person's personalised behavioural profile.
Carer receives ranked, evidence-based non-pharmacological interventions and implements the best fit.
Structured outcome captured — distress before/after, engagement time, effectiveness.
Analytics update the model. Recommendation accuracy improves for that individual with every use.
The engine never alters prescribing. It generates the structured, auditable evidence that supports Clinician-led Medication Review and safer deprescribing — with clinical authority remaining with the doctor.
Six workflows CalmPath is built for.
Afternoon agitation management
1950s jazz surfaced as Mr Brown's top-ranked intervention with 85% historical success; distress falls 4/5 → 2/5, and confidence in that recommendation strengthens.
Early UTI detection & escalation
The daily check-in flags new confusion and reduced appetite for Mrs Patel; decision support prompts a urinary check and auto-generates an SBAR handover and GP summary within minutes.
Clinician-led Medication Review
A GP reviews CalmPath's Medication-Outcome Correlation Engine dashboard: PRN antipsychotic use down 40% over 3 months alongside stable mood and engagement — evidence to support a safe dose reduction.
CQC inspection preparation
The registered manager pulls a real-time CQC Evidence Dashboard covering Safe, Effective, Caring, Responsive and Well-Led — ready in minutes, not weeks.
Family reassurance & engagement
A daughter 200 miles away sees her mother's weekly mood trend and recent photos through the Family Portal — trust without another anxious phone call.
Carer wellbeing intervention
A declining pattern in a carer's daily check-in privately flags to the registered manager, who initiates a supportive conversation before burnout becomes turnover.
Deliberately scoped to the defensible clinical core.
The MVP proves the innovation and delivers measurable value without over-building before customer validation. Success is gated on 3–5 onboarded pilot sites, ≥75% user satisfaction, consistent daily outcome capture and zero security or compliance incidents.
| Feature | Target month |
|---|---|
| Personalised dementia profile | Month 2 |
| Non-pharmacological protocol library (15–20 protocols) | Month 3 |
| Closed-loop outcome capture | Month 4 |
| Daily morning check-in | Month 4 |
| Clinical decision support (5 high-priority conditions) | Month 5 |
| Smart escalation with SBAR generation | Month 6 |
| Consent & Mental Capacity Act compliance framework | Month 6 |
| Basic analytics & CQC Safe-domain reporting | Month 7 |
No competitor holds intervention outcomes and PRN medication in a single data model.
| Capability | Generic care software | Remote monitoring | CalmPath |
|---|---|---|---|
| Personalised, ranked intervention recommendations | — | — | ● |
| Structured outcome capture per intervention | — | — | ● |
| Medication-Outcome Correlation Engine in one data model | — | — | ● |
| Automated SBAR generation & GP summary | — | — | ● |
| Standardised daily observation schema | — | ● | ● |
| Constraint-Aware Predictive Risk Flagging | — | — | ● |
| Continuous CQC evidence as a byproduct of care | — | — | ● |
A subscription that pays for itself the first time it reduces inappropriate PRN use.
A typical 60-bed care home spends £15,000–£25,000 annually on PRN psychotropic medication. A conservative 15–25% reduction in inappropriate PRN medication use — a core Business Objective — alone exceeds CalmPath's annual subscription within the first year.
- Personalised dementia profile & closed-loop intervention engine
- Structured daily observation & clinical decision support
- Automated SBAR escalation with GP summary drafting
- CQC Safe-domain evidence reporting
- Consent & Mental Capacity Act compliance framework
- Wellbeing & Companionship
- Workforce Enablement
- Family Portal
- Medication-Outcome Correlation Reporting
- 20–30% modelled attach rate across the base
- Site configuration & carer training
- Resident profile & life-story data setup
- Protocol library tailoring
- Pilot cohort onboarding fee waived in exchange for structured feedback
- Fee offsets direct implementation cost, not a profit centre
Effective cost per person under care: approximately £25–£124 per year — negligible against £30,000–£50,000+ annual per-resident care cost.
EBITDA Positive & Profitable by Year 2. 86%+ gross margins from Year 1.
- MVP with 3–5 pilot sites
- 44 active sites by year-end
- £64,130 revenue · 86% gross margin
- Operating cash flow positive from Month 10
- 259 active sites
- £629,620 revenue · 87% gross margin
- Profitability in Year 2 — EBITDA positive · net profit £215,144
- Medication-Outcome Correlation Engine at scale
- 666 active sites
- £1,760,386 revenue · 88% gross margin
- Net profit £804,639
- Partnerships with ICBs and major care groups
Care leadership meets end-to-end technical execution.
MSc Biotechnology (Coventry, 2023). Level 5 Diploma in Leadership for Health and Social Care. 3+ years of senior care leadership managing rotas, CQC compliance, safeguarding and Mental Capacity Act 2005 practice. CalmPath is designed from CQC's five key lines of enquiry — not retrofitted to them.
B.Tech Computer Science & Engineering (D.C.R.U.S.T, 2018). End-to-end web development, front-end architecture and AI-assisted development. Prior B2B inside-sales development — an unusual combination that pairs technical delivery with a working understanding of customer acquisition.
A dedicated AI/ML engineer joins in Month 20 for later-phase predictive analytics and cross-cohort medication-correlation modelling. Phase 1–2 is deliberately scoped to rule-based, explainable logic appropriate for a patient-safety-critical context.
Stop measuring dementia care by what didn't happen.
We're onboarding 3–5 pilot sites into the founding cohort with waived onboarding fees in exchange for structured feedback. Turn everyday care into the evidence CQC, families and clinicians need.